Coherus BioSciences Inc. (CHRS)

AI Score

Unlock

0.78

-0.04 (-4.49%)

At close: Apr 04, 2025, 3:59 PM

0.79

0.82%

Pre-market: Apr 07, 2025, 04:05 AM EDT

Coherus BioSciences Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	125.99M	102.89M	63.55M	417.19M	541.16M	177.67M	72.36M	126.91M	124.95M	158.23M	150.39M	39.55M	14.55M
Short-Term Investments	n/a	14.86M	128.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	440K	440K	440K	240K	785K	785K	785K	785K	n/a	n/a	n/a
Other Long-Term Assets	50.47M	71.27M	49.47M	34.49M	27.63M	14.14M	16.89M	19.36M	39.2M	40.09M	28.79M	27K	129K
Receivables	122.33M	260.52M	109.96M	123.02M	157.05M	141.99M	n/a	n/a	1.86M	1.56M	4.23M	385K	158K
Inventory	70.09M	62.6M	115.05M	93.25M	92.19M	55.07M	1.66M	n/a	-4.84M	-4.36M	-8.2M	1.00	10.03M
Other Current Assets	11.53M	11.1M	22.92M	n/a	5.61M	4.96M	50K	202K	3.05M	2.86M	4.03M	50K	110K
Total Current Assets	341.58M	475.63M	416.7M	633.47M	790.39M	374.73M	72.36M	126.91M	124.95M	158.23M	150.39M	45.68M	24.8M
Property-Plant & Equipment	2.84M	11.03M	8.75M	7.81M	20.06M	16.49M	6.66M	12.77M	10.77M	10.5M	4.47M	1.74M	1.6M
Goodwill & Intangibles	53.65M	71.67M	5.93M	3.56M	3.56M	3.56M	3.56M	3.56M	3.56M	3.56M	3.56M	n/a	n/a
Total Long-Term Assets	106.95M	153.97M	64.15M	45.87M	51.26M	34.2M	27.11M	35.7M	53.54M	54.16M	36.83M	1.77M	1.73M
Total Assets	448.53M	629.6M	480.85M	679.33M	841.65M	408.93M	99.47M	162.61M	178.49M	212.38M	187.22M	47.45M	26.53M
Account Payables	28.46M	35.22M	11.53M	16.16M	15.2M	25.98M	15.29M	15.71M	20.58M	29.5M	10.8M	3.69M	3.9M
Deferred Revenue	n/a	n/a	n/a	n/a	-3.13M	-2.2M	n/a	8.82M	1.96M	50.95M	23.99M	14.28M	2.02M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.2M	1.74M
Other Current Liabilities	254.53M	3.3M	n/a	123.66M	n/a	n/a	419K	3.63M	26.89M	20.91M	37.55M	25.82M	3.13M
Total Current Liabilities	282.98M	331.77M	54.46M	79.03M	81.53M	114.97M	33.26M	28.39M	56.38M	106.02M	51.78M	53.7M	11.25M
Long-Term Debt	231.51M	473.37M	471.06M	408.28M	404.02M	178.39M	103.09M	101.61M	100.26M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	64.92M	11.46M	3.47M	750K	1.05M	102K	1.71M	2.07M	1.83M	67.96M	28.78M	7.56M	12K
Total Long-Term Liabilities	297.54M	491.26M	563.8M	502.58M	479.15M	303.71M	138.06M	132.08M	159.13M	219.31M	120.46M	36.13M	6.09M
Total Liabilities	580.52M	823.03M	618.26M	581.61M	560.67M	303.71M	138.06M	132.08M	159.13M	219.31M	120.46M	89.83M	17.34M
Total Debt	231.51M	480.84M	471.06M	408.28M	404.02M	178.39M	103.09M	101.41M	100.26M	n/a	n/a	4.2M	1.74M
Common Stock	12K	11K	8K	7K	7K	7K	7K	6K	5K	4K	3K	1K	1K
Retained Earnings	-1.55B	-1.58B	-1.34B	-1.05B	-762.75M	-895M	-984.83M	-775.49M	-537.32M	-409.99M	-186.72M	-99.59M	-45.96M
Comprehensive Income	-275K	-248K	-249K	-270K	-270K	-558K	-282K	-750K	-630K	-401K	-525K	-625K	-226K
Shareholders Equity	-131.99M	-193.43M	-137.42M	97.73M	280.97M	105.21M	-38.59M	30.54M	19.35M	-6.93M	66.76M	-42.38M	9.19M
Total Investments	n/a	14.86M	128.13M	440K	440K	240K	785K	785K	785K	785K	n/a	n/a	n/a